Nasdaq gets tough on small Chinese IPOs, as an AI-fueled energy storage boom takes off
For a market that basically prides itself on protecting investors… I have to say I'm amazed that it has taken so long.
PomDoctor completes U.S. listing ahead of looming Nasdaq crackdown
The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million Key…
INDUSTRY NEWS WRAP: Nasdaq to crack down on small Chinese listings
The exchange operator’s proposed new rules would require all new Chinese IPOs to raise at least $25 million By Doug Young The Nasdaq on Wednesday proposed new listing standards…
Hong Kong IPOs explode in first half as China Inc. abandons New York
Hong Kong listings by 44 companies raised $13.6 billion in the first six months of 2025, accounting for a quarter of the world’s total IPO fundraising Key Takeaways: Hong Kong…
BRIEF: EPWK ends flat in Nasdaq trading debut
Gig worker crowdsourcing platform operator EPWK Holdings Inc. (EPWK.US) made a muted trading debut on Thursday, closing up a slight 0.24% at $4.11 in its first trading day on the…
BRIEF: Ascentage Pharma prices U.S. IPO at 20% discount, to raise up to $130 million
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) announced Friday that it will offer 7.325 million American Depositary Shares (ADS) in its upcoming U.S. listing at an issue price of $17.25…
BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Monday, a necessary step before it can make an overseas…
Recent Articles
RELATED ARTICLES
-
Sungrow powers up to meet soaring demand from AI data centers
300274.SHE - Hong Kong IPOs explode in first half as China Inc. abandons New York
- NEWS WRAP: Hithium likely to continue Hong Kong IPO process after initial application
- INDUSTRY NEWS WRAP: Nasdaq to crack down on small Chinese listings
- Fading revenue fails to cast shadow over Xinzi’s IPO ambitions
- QMSK supersizes U.S. listing as Nasdaq cracks down on Chinese companies
-
PomDoctor completes U.S. listing ahead of looming Nasdaq crackdown
POM.US
